Riskpilot← Back to searchSign inGet full accessBRYNKLINIKKEN AS
ASActiveOrg 998783267Østensjøveien 36, 0667 OsloGeneral medical practice activities · NACE 8621Est. 20125 employees
Revenue 2025
NOK 5,5M
+12% vs 2024
EBITDA margin
-1.0%
+90% vs 2024
Equity ratio
28.2%
Financial strength
Net profit 2025
NOK -116K
+76% vs 2024
| Revenue | NOK 5,5M | +12% |
| EBITDA | NOK -56K | +90% |
| Net profit | NOK -116K | +76% |
| Total assets | NOK 733K | -11% |
| Equity | NOK 206K | -36% |
| Employees | 5 | — |
Legal name
BRYNKLINIKKEN AS
Org number
998783267
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
4. september 2012
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Kontorfellesskap for legene tilknyttet legesenteret.
Address
Østensjøveien 36, 0667 Oslo
Phone
+4722066550
Email
post@brynklinikken.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 13 645 | 15 134 | 15 433 | 4 880 | 5 484 |
| Staff expenses | −2 450 | −2 713 | −2 955 | −2 295 | −2 431 |
| EBITDA | 1 487 | 2 063 | 1 445 | −537 | −56 |
| Depreciation & amort. | −148 | −141 | −123 | −94 | −92 |
| EBIT | 1 340 | 1 923 | 1 322 | −631 | −148 |
| Net financials | −0 | −0 | −1 | 13 | 0 |
| Profit before tax | 1 340 | 1 922 | 1 321 | −619 | −148 |
| Tax | 295 | 423 | 291 | −137 | −32 |
| Net profit | 1 045 | 1 499 | 1 030 | −482 | −116 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 418 | 2 953 | 2 352 | 820 | 733 |
| Equity | 275 | 274 | 804 | 322 | 206 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 143 | 2 679 | 1 548 | 498 | 527 |
| Total debt | 2 143 | 2 679 | 1 548 | 498 | 527 |
EBITDA margin
-1.0%
This company
15.8%
Market median
-106% vs market
20212025
Equity ratio
28.2%
This company
38.2%
Market median
-26% vs market
20212025
Return on equity
-56.2%
This company
18.4%
Market median
-405% vs market
20212025
Net profit margin
-2.1%
This company
8.1%
Market median
-126% vs market
20212025
Asset turnover
7.48×
This company
1.12×
Market median
+568% vs market
20212025
Debt / equity
2.55×
This company
0.62×
Market median
-311% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BRYNKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marius Tyssvang | Board of Directors | 0 companies |
| Pooja Verma | Board of Directors | 0 companies |
| Arnt Röch-Pettersen | Board of Directors | 0 companies |
| Sohail Aslam | Chairman | 0 companies |